Microbes in Gastrointestinal Health and Disease

Gastroenterology

Volumn 136, Issue 1, 2009, Pages 65-80

  Neish, Andrew S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; BACTERIAL CELL; CELL FUNCTION; DRUG TARGETING; ECOSYSTEM; EPITHELIUM CELL; EUKARYOTE; GASTROINTESTINAL DISEASE; GENOME; HUMAN; IMMUNOMODULATION; INFLAMMATION; INTESTINE FLORA; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; REVIEW; SIGNAL TRANSDUCTION; SYMBIONT; SYMBIOSIS; TAXONOMY; ANIMAL; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; EVOLUTION; GASTROINTESTINAL TRACT; HYGIENE; IMMUNITY; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL PROLIFERATION; CELL SURVIVAL; EVOLUTION; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; HYGIENE; IMMUNITY; INTESTINAL MUCOSA; PROBIOTICS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; SYMBIOSIS;

EID: 59849113547     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.10.080     Document Type: Review

References (158)

1. McFall-Ngai M. Adaptive immunity: care for the community. Nature 445 (2007) 153
2. McFall-Ngai M.J. Identifying "prime suspects": symbioses and the evolution of multicellularity. Comp Biochem Physiol B Biochem Mol Biol 129 (2001) 711-723
3. McFall-Ngai M.J. Unseen forces: the influence of bacteria on animal development. Dev Biol 242 (2002) 1-14
4. Dale C., and Moran N.A. Molecular interactions between bacterial symbionts and their hosts. Cell 126 (2006) 453-465
5. Hickman C. How have bacteria contributed to the evolution of multicellular animals?. In: McFall-Ngai M.J. (Ed). The influence of cooperative bacteria on animal host biology (2005), Cambridge University Press, New York 3-32
6. Dethlefsen L., McFall-Ngai M., and Relman D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449 (2007) 811-818
7. Flint H. The rumen microbial ecosystem-some recent developments. Trends Microbiol 2 (1997) 483-488
8. Warnecke F., Luginbuhl P., Ivanova N., et al. Metagenomic and functional analysis of hindgut microbiota of a wood-feeding higher termite. Nature 450 (2007) 560-565
9. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
10. Sansonetti P.J. War and peace at mucosal surfaces. Nat Rev Immunol 4 (2004) 953-964
11. Sansonetti P.J. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 7 (2006) 1237-1242
12. Meylan E., Tschopp J., and Karin M. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
13. Ishii K.J., Koyama S., Nakagawa A., et al. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3 (2008) 352-363
14. Migeotte I., Communi D., and Parmentier M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17 (2006) 501-519
15. Babbin B.A., Jesaitis A.J., Ivanov A.I., et al. Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J Immunol 179 (2007) 8112-8121
16. Pujol N., Link E.M., Liu L.X., et al. A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr Biol 11 (2001) 809-821
17. Ferrandon D., Imler J.L., Hetru C., et al. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections. Nat Rev Immunol 7 (2007) 862-874
18. Abreu M.T., Fukata M., and Arditi M. TLR signaling in the gut in health and disease. J Immunol 174 (2005) 4453-4460
19. -/-; NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol 178 (2007) 6522-6532
20. Jones R.M., Wu H., Wentworth C., et al. Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3 (2008) 233-244
21. Kim D.H., and Ausubel F.M. Evolutionary perspectives on innate immunity from the study of Caenorhabditis elegans. Curr Opin Immunol 17 (2005) 4-10
22. Tzou P., Ohresser S., Ferrandon D., et al. Tissue-specific inducible expression of antimicrobial peptide genes in Drosophila surface epithelia. Immunity 13 (2000) 737-748
23. Ayabe T., Satchell D.P., Wilson C.L., et al. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1 (2000) 113-118
24. Salzman N.H., Ghosh D., Huttner K.M., et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422 (2003) 522-526
25. Cash H.L., Whitham C.V., Behrendt C.L., et al. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313 (2006) 1126-1130
26. Hooper L.V., Stappenbeck T.S., Hong C.V., et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4 (2003) 269-273
27. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4 (2004) 181-189
28. Terada L.S. Specificity in reactive oxidant signaling: think globally, act locally. J Cell Biol 174 (2006) 615-623
29. Ogier-Denis E., Mkaddem S.B., and Vandewalle A. NOX enzymes and Toll-like receptor signaling. Semin Immunopathol 30 (2008) 291-300
30. Schneeweiss H., and Renwrantz L. Analysis of the attraction of haemocytes from Mytilus edulis by molecules of bacterial origin. Dev Comp Immunol 17 (1993) 377-387
31. Ha E.-M., Oh C.-T., Ryu J.-H., et al. An antioxidant system required for host protection against gut infection in drosophila. Dev Cell 8 (2005) 125-132
32. Ha E.-M., Oh C.-T., Bae Y.S., et al. A direct role for dual oxidase in drosophila gut immunity. Science 310 (2005) 847-850
33. Pull S.L., Doherty J.M., Mills J.C., et al. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci U S A 102 (2005) 99-104
34. Kotchoni S.O., and Gachomo E.W. The reactive oxygen species network pathways: an essential prerequisite for perception of pathogen attack and the acquired disease resistance in plants. J Biosci 31 (2006) 389-404
35. Pauly N., Pucciariello C., Mandon K., et al. Reactive oxygen and nitrogen species and glutathione: key players in the legume-Rhizobium symbiosis. J Exp Bot 57 (2006) 1769-1776
36. Tanaka A., Christensen M.J., Takemoto D., et al. Reactive oxygen species play a role in regulating a fungus-perennial ryegrass mutualistic interaction. Plant Cell 18 (2006) 1052-1066
37. Kumar A., Wu H., Collier-Hyams L.S., et al. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J 26 (2007) 4457-4466
38. Bedard K., and Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87 (2007) 245-313
39. Chiarugi P., and Buricchi F. Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications. Antioxid Redox Signal 9 (2007) 1-24
40. Rokutan K., Kawahara T., Kuwano Y., et al. NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid Redox Signal 8 (2006) 1573-1582
41. Lee J., Mo J.H., Katakura K., Alkalay I., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8 (2006) 1327-1336
42. Guo L., Lim K.B., Gunn J.S., Bainbridge B., et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276 (1997) 250-253
43. Melmed G., Thomas L.S., Lee N., et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 170 (2003) 1406-1415
44. Lotz M., Gutle D., Walther S., et al. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 203 (2006) 973-984
45. Otte J.M., Cario E., and Podolsky D.K. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126 (2004) 1054-1070
46. Xiao H., Gulen M.F., Qin J., et al. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26 (2007) 461-475
47. Bates J.M., Akerlund J., Mittge E., et al. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2 (2007) 371-382
48. Miao E.A., Andersen-Nissen E., Warren S.E., et al. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin Immunopathol 29 (2007) 275-288
49. Ley R.E., Peterson D.A., and Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006) 837-848
50. Marchesi J., and Shanahan F. The normal intestinal microbiota. Curr Opin Infect Dis 20 (2007) 508-513
51. Hooper L.V., and Gordon J.I. Commensal host-bacterial relationships in the gut. Science 292 (2001) 1115-1118
52. Xu J., Mahowald M.A., Ley R.E., et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 5 (2007) e156
53. Gill S.R., Pop M., Deboy R.T., et al. Metagenomic analysis of the human distal gut microbiome. Science 312 (2006) 1355-1359
54. Backhed F., Ley R.E., Sonnenburg J.L., et al. Host-bacterial mutualism in the human intestine. Science 307 (2005) 1915-1920
55. Scupham A.J., Presley L.L., Wei B., et al. Abundant and diverse fungal microbiota in the murine intestine. Appl Environ Microbiol 72 (2006) 793-801
56. Eckburg P.B., Bik E.M., Bernstein C.N., et al. Diversity of the human intestinal microbial flora. Science 308 (2005) 1635-1638
57. Rawls J.F., Mahowald M.A., Ley R.E., and Gordon J.I. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127 (2006) 423-433
58. Turnbaugh P.J., Ley R.E., Hamady M., et al. The human microbiome project. Nature 449 (2007) 804-810
59. Frank D.N., St Amand A.L., Feldman R.A., et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104 (2007) 13780-13785
60. Peterson D.A., Frank D.N., Pace N.R., et al. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3 (2008) 417-427
61. Lupp C., Robertson M.L., Wickham M.E., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2 (2007) 119-129
62. Hooper L.V., Bry L., Falk P.G., et al. Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. Bioessays 20 (1998) 336-343
63. Backhed F., Ding H., Wang T., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101 (2004) 15718-15723
64. Turnbaugh P.J., Ley R.E., Mahowald M.A., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006) 1027-1031
65. Ley R.E., Turnbaugh P.J., Klein S., et al. Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006) 1022-1023
66. Dumas M.-E., Barton R.H., Toye A., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 103 (2006) 12511-12516
67. Cani P.D., and Delzenne N.M. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 10 (2007) 729-734
68. Hooper L.V., Midtvedt T., and Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22 (2002) 283-307
69. Topping D.L., and Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81 (2001) 1031-1064
70. Bergman E. Energy contribution of volitile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70 (1990) 567-590
71. Wachtershauser A., and Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 39 (2000) 164-171
72. Hamer H.M., Jonkers D., Venema K., et al. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27 (2008) 104-119
73. Kumar A, Collier-Hyams LS, Wu H, et al. The bacterial fermentation product butyrate influences epithelial signaling via ROS mediated changes in Cullin-1 neddylation. J Immunol (in press).
74. Vernia P., Annese V., Bresci G., et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 33 (2003) 244-248
75. Madara J.L., Nash S., Moore R., et al. Structure and function of the intestinal epithelial barrier in health and disease. Monogr Pathol 31 (1990) 306-324
76. Laukoetter M.G., Nava P., and Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 14 (2008) 401-407
77. Ismail A.S., and Hooper L.V. Epithelial cells and their neighbors. IV. Bacterial contributions to intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 289 (2005) G779-G784
78. Madsen K., Cornish A., Soper P., et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121 (2001) 580-591
79. Smith K., McCoy K.D., and Macpherson A.J. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 19 (2007) 59-69
80. Hooper L.V., Wong M.H., Thelin A., et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001) 881-884
81. Stappenbeck T.S., Hooper L.V., and Gordon J.I. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99 (2002) 15451-15455
82. Sonnenburg J.L., Chen C.T., and Gordon J.I. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 4 (2006) e413
83. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
84. Cario E., Gerken G., and Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132 (2007) 1359-1374
85. Katakura K., Lee J., Rachmilewitz D., et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115 (2005) 695-702
86. Zaph C., Troy A.E., Taylor B.C., et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446 (2007) 552-556
87. Nenci A., Becker C., Wullaert A., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446 (2007) 557-561
88. Ben-Neriah Y., and Schmidt-Supprian M. Epithelial NF-kappaB maintains host gut microflora homeostasis. Nat Immunol 8 (2007) 479-481
89. Chen L.W., Egan L., Li Z.W., et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 9 (2003) 575-581
90. McVay L.D., Keilbaugh S.A., Wong T.M., et al. Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest 116 (2006) 2914-2923
91. Gewirtz A.T. Flag in the crossroads: flagellin modulates innate and adaptive immunity. Curr Opin Gastroenterol 22 (2006) 8-12
92. Zeng H., Carlson A.Q., Guo Y., et al. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 171 (2003) 3668-3674
93. Vijay-Kumar M., Sanders C.J., Taylor R.T., et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 117 (2007) 3909-3921
94. Vijay-Kumar M., Wu H., Jones R., et al. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol 169 (2006) 1686-1700
95. Zeng H., Wu H., Sloane V., et al. Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. Am J Physiol Gastrointest Liver Physiol 290 (2006) G96-G108
96. Burdelya L.G., Krivokrysenko V.I., Tallant T.C., et al. An agonist of Toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320 (2008) 226-230
97. Vijay-Kumar M., Aitken J.D., Kumar A., et al. Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced typhoid-like disease. Infect Immun 76 (2008) 1276-1281
98. Vijay-Kumar M., Aitken J.D., Sanders C.J., et al. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol 180 (2008) 8280-8285
99. Carlson R.M., Vavricka S.R., Eloranta J.J., et al. fMLP induces Hsp27 expression, attenuates NF-kappaB activation, and confers intestinal epithelial cell protection. Am J Physiol Gastrointest Liver Physiol 292 (2007) G1070-G1078
100. Fujiya M., Musch M.W., Nakagawa Y., et al. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe 1 (2007) 299-308
101. Kelly D., Conway S., and Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 26 (2005) 326-333
102. Iyer C., Kosters A., Sethi G., et al. Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kB and MAPK signalling. Cell Microbiol 10 (2008) 1441-1452
103. Neish A.S. Microbial interference with host inflammatory responses. In: Hecht G. (Ed). Microbial pathogenesis and the intestinal epithelial cell (2003), ASM Press, Washington, DC 175-190
104. Yan F., Cao H., Cover T.L., et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132 (2007) 562-575
105. Menard S., Candalh C., Bambou J.C., et al. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53 (2004) 821-828
106. Pena J.A., and Versalovic J. Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 5 (2003) 277-285
107. Madsen K.L., Doyle J.S., Jewell L.D., et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116 (1999) 1107-1114
108. Kelly D., Campbell J.I., King T.P., et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5 (2004) 104-112
109. Neish A.S., Gewirtz A.T., Zeng H., et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289 (2000) 1560-1563
110. Tien M.-T., Girardin S.E., Regnault B., et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176 (2006) 1228-1237
111. Petrof E.O., Kojima K., Ropeleski M.J., et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127 (2004) 1474-1487
112. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18 (2000) 621-663
113. Kim D.W., Lenzen G., Page A.L., et al. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A 102 (2005) 14046-14051
114. Angot A., Vergunst A., Genin S., et al. Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog 3 (2007) e3
115. Rytkonen A., and Holden D.W. Bacterial interference of ubiquitination and deubiquitination. Cell Host Microbe 1 (2007) 13-22
116. Collier-Hyams L.S., Sloane V., Batten B.C., et al. Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of Cullin-1. J Immunol 175 (2005) 4194-4198
117. Lee W.J. Bacterial-modulated signaling pathways in gut homeostasis. Sci Signal 1 (2008) pe24
118. Cooper M.D., and Alder M.N. The evolution of adaptive immune systems. Cell 124 (2006) 815-822
119. Macdonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 (2005) 1920-1925
120. Neutra M.R., Mantis N.J., and Kraehenbuhl J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2 (2001) 1004-1009
121. Kelly D., King T., and Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 622 (2007) 58-69
122. Jang M.H., Kweon M.-N., Iwatani K., et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci U S A 101 (2004) 6110-6115
123. Mazmanian S.K., Liu C.H., Tzianabos A.O., et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122 (2005) 107-118
124. Zaph C., Du Y., Saenz S.A., et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 205 (2008) 2191-2198
125. Mazmanian S.K., Round J.L., and Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008) 620-625
126. Macpherson A.J., Geuking M.B., and McCoy K.D. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 115 (2005) 153-162
127. Macpherson A.J., Gatto D., Sainsbury E., et al. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288 (2000) 2222-2226
128. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004) 1662-1665
129. Peterson D.A., McNulty N.P., Guruge J.L., et al. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2 (2007) 328-339
130. Strachan D.P. Hay fever, hygiene, and household size. BMJ 299 (1989) 1259-1260
131. Bach J.-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347 (2002) 911-920
132. von Mutius E. Allergies, infections and the hygiene hypothesis-the epidemiological evidence. Immunobiology 212 (2007) 433-439
133. Guarner F., Bourdet-Sicard R., Brandtzaeg P., et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 275-284
134. Wills-Karp M., Santeliz J., and Karp C.L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1 (2001) 69-75
135. Noverr M.C., and Huffnagle G.B. Does the microbiota regulate immune responses outside the gut?. Trends Microbiol 12 (2004) 562-568
136. Di Giacinto C., Marinaro M., Sanchez M., et al. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174 (2005) 3237-3246
137. Boirivant M., and Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol 23 (2007) 679-692
138. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008) 577-594
139. Strober W., Fuss I., and Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 117 (2007) 514-521
140. Garrett W.S., Lord G.M., Punit S., et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131 (2007) 33-45
141. Hecht G.A. Inflammatory bowel disease-live transmission. N Engl J Med 358 (2008) 528-530
142. Ryu J.-H., Kim S.-H., Lee H.-Y., et al. Innate immune homeostasis by the homeobox gene caudal and commensal-gut mutualism in Drosophila. Science 319 (2008) 777-782
143. Stecher B., and Hardt W.-D. The role of microbiota in infectious disease. Trends Microbiol 16 (2008) 107-114
144. Vollaard E.J., and Clasener H.A. Colonization resistance. Antimicrob Agents Chemother 38 (1994) 409-414
145. Corr S.C., Li Y., Riedel C.U., et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 104 (2007) 7617-7621
146. Kaper J.B., and Sperandio V. Bacterial cell-to-cell signaling in the gastrointestinal tract. Infect Immun 73 (2005) 3197-3209
147. Kelly C.P., Pothoulakis C., and LaMont J.T. Clostridium difficile colitis. N Engl J Med 330 (1994) 257-262
148. Top J., Willems R., and Bonten M. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 52 (2008) 297-308
149. Pamer E.G. Immune responses to commensal and environmental microbes. Nat Immunol 8 (2007) 1173-1178
150. Brandl K., Plitas G., Mihu C.N., et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455 (2008) 804-807
151. World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, 2001. http://www.who.int/foodsafety/publications/fs_management/en/probiotics.p df
152. Hord N.G. Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics. Annu Rev Nutr 28 (2008) 1-17
153. Park J., and Floch M.H. Prebiotics, probiotics, and dietary fiber in gastrointestinal disease. Gastroenterol Clin North Am 36 (2007) 47-63
154. Ouwehand A.C. Antiallergic effects of probiotics. J Nutr 137 (2007) 794S-797S
155. Seifert S., and Watzl B. Inulin and oligofructose: review of experimental data on immune modulation. J Nutr 137 (2007) 2563S-2567S
156. Gibson G.R., Probert H.M., van Loo J.A.E., et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nut Res Rev 17 (2004) 259-275
157. Besselink M.G., van Santvoort H.C., Buskens E., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 651-659
158. Land M.H., Rouster-Stevens K., Woods C.R., et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115 (2005) 178-181